From: Causal associations of Sjögren’s syndrome with cancers: a two-sample Mendelian randomization study
Cancer types | Cochran’s Q test | IVW (random) | |||
---|---|---|---|---|---|
Method | Q | Q pval | OR (95% CI) | P value | |
Overall breast cancer | MR Egger | 64.3370 | 1.94E − 10 | 0.9952 (0.9649, 1.0264) | 0.7595 |
IVW | 65.1903 | 3.73E − 10 | |||
Luminal A-like breast cancer | MR Egger | 27.1406 | 0.0013 | 1.0103 (0.9761, 1.0457) | 0.5597 |
IVW | 27.1431 | 0.0025 | |||
Luminal B/HER2-positive-like breast cancer | MR Egger | 16.4500 | 0.0581 | NE | NE |
IVW | 17.3952 | 0.0661 | |||
Luminal B/HER2-negative-like breast cancer | MR Egger | 9.9122 | 0.3576 | NE | NE |
IVW | 10.6899 | 0.3822 | |||
HER2-enriched-like breast cancer | MR Egger | 8.2534 | 0.5088 | NE | NE |
IVW | 8.6417 | 0.5664 | |||
Triple-negative breast cancer | MR Egger | 8.9561 | 0.4413 | NE | NE |
IVW | 8.9662 | 0.5353 | |||
Overall lung cancer | MR Egger | 13.2712 | 0.1029 | NE | NE |
IVW | 13.2712 | 0.1507 | |||
Lung adenocarcinoma | MR Egger | 9.8468 | 0.2759 | NE | NE |
IVW | 9.8716 | 0.3610 | |||
Squamous cell lung cancer | MR Egger | 19.2431 | 0.0136 | 1.0343 (0.9198, 1.1631) | 0.5731 |
IVW | 22.0099 | 0.0088 | |||
Prostate cancer | MR Egger | 8.7033 | 0.3679 | NE | NE |
IVW | 15.8168 | 0.0708 | |||
Endometrial cancer | MR Egger | 12.0095 | 0.2844 | NE | NE |
IVW | 19.0442 | 0.0603 | |||
Lymphomas | MR Egger | 29.8692 | 0.0009 | 1.0010 (1.0005, 1.0015) | 0.0002 |
IVW | 34.6995 | 0.0003 | |||
Liver and bile duct cancer | MR Egger | 3.9196 | 0.8643 | NE | NE |
IVW | 3.9221 | 0.9165 | |||
Cancer of urinary tract | MR Egger | 18.8126 | 0.0427 | 0.9996 (0.9992, 1.0000) | 0.0281 |
IVW | 19.0671 | 0.0599 | |||
Thyroid cancer | MR Egger | 8.2245 | 0.3132 | NE | NE |
IVW | 8.9707 | 0.3448 | |||
Oral cavity and pharyngeal cancer | MR Egger | 20.4960 | 0.0086 | 1.1068 (0.9445, 1.2970) | 0.2098 |
IVW | 25.2313 | 0.0027 |